These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. CD56+ lymphoma with skin involvement: clinicopathologic features and classification. Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371 [TBL] [Abstract][Full Text] [Related]
30. Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature. Ruggiero A; Maurizi P; Larocca LM; Arlotta A; Riccardi R Haematologica; 2006 Dec; 91(12 Suppl):ECR48. PubMed ID: 17194654 [TBL] [Abstract][Full Text] [Related]
31. CD4+ CD56+ hematodermic neoplasm and plasmacytoid dendritic cell tumor: case report and review of the literature. Campbell SM; Moad JC; Sammons DL; Zirwas M Cutis; 2012 Jun; 89(6):278-83. PubMed ID: 22838092 [TBL] [Abstract][Full Text] [Related]
32. Progress in understanding and managing natural killer-cell malignancies. Oshimi K Br J Haematol; 2007 Nov; 139(4):532-44. PubMed ID: 17916099 [TBL] [Abstract][Full Text] [Related]
33. Solitary cutaneous nodule of blastic plasmacytoid dendritic cell neoplasm progressing to overt leukemia cutis after chemotherapy: immunohistology and FISH analysis confirmed the diagnosis. Kaune KM; Baumgart M; Bertsch HP; Mitteldorf C; Müller-Hermelink HK; Haase D; Ghadimi BM; Schön MP; Neumann C Am J Dermatopathol; 2009 Oct; 31(7):695-701. PubMed ID: 19684511 [TBL] [Abstract][Full Text] [Related]
34. [Agranular CD4+ CD56+ CD123+ hematodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization: 2 cases]. Machet L; De Muret A; Wiezberka E; Bernez A; Abdallah-Lotf M; Linassier C; Petrella T Ann Dermatol Venereol; 2004 Nov; 131(11):969-73. PubMed ID: 15602384 [TBL] [Abstract][Full Text] [Related]
35. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification. Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940 [TBL] [Abstract][Full Text] [Related]
37. CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate. Leitenberger JJ; Berthelot CN; Polder KD; Pro B; McLaughlin P; Jones D; Duvic M J Am Acad Dermatol; 2008 Mar; 58(3):480-4. PubMed ID: 18280345 [TBL] [Abstract][Full Text] [Related]
38. [Retrospective analysis of 4 cases of the so-called blastic NK-cell lymphoma, with reference to the 2008 WHO classification of tumours of haematopoietic and lymphoid tissues]. Zheng YY; Chen G; Zhou XG; Jin Y; Xie JL; Zhang SH; Zhang YN Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):600-5. PubMed ID: 21092587 [TBL] [Abstract][Full Text] [Related]
39. CD4+ CD56+ blastic tumor of the skin: cytogenetic observations and further evidence of an origin from plasmocytoid dendritic cells. Hallermann C; Middel P; Griesinger F; Gunawan B; Bertsch HP; Neumann C Eur J Dermatol; 2004; 14(5):317-22. PubMed ID: 15358570 [TBL] [Abstract][Full Text] [Related]
40. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients. Akiyama T; Okino T; Konishi H; Wani Y; Notohara K; Tsukayama C; Tsunoda T; Tasaka T; Masaki Y; Sugihara T; Sadahira Y Pathol Int; 2008 Oct; 58(10):626-34. PubMed ID: 18801082 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]